Leading global vaccine products by market share 2017 and 2024

This statistic displays a projection of the top 5 global vaccine products and their respective market share worldwide in 2017 and 2024. Pfizer's pneumococcal vaccine, Prevnar 13, is expected to accumulate around 16 percent of the global market based on revenues by 2024. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.

Top 5 global vaccine products by market share in 2017 and 2024

20172024*
---
---
---
---
---
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

June 2018

Region

Worldwide

Survey time period

as of May 2018

Supplementary notes

Statistic is ranked by 2024 market share based on revenues.
* Projected.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Sanofi"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.